Department of Medicine

You are here

VECD Consortium for Global Health Fellows

Project Dates: 7/1/2012 – 6/30/2022

Cornell is a member of the Vanderbilt-Emory-Cornell-Duke Consortium (VECD Consortium) which provides global health research training for pre- and post-doctoral fellows at our research sites in Haiti, Tanzania, Ghana, and India. The consortium is in its 6th year of funding and has provided research training for nearly 100 global health fellows since its inception. Trainee research topics have included infectious diseases, cancer, heart and lung disease, stroke, diabetes, nutrition, behavioral and mental health issues (including substance abuse), women's and children's health, ophthalmic disease, oral health, neurology, and animal-human health. The 1-year global health fellowship includes a strategic mentoring support plan, including a substantial preparation phase prior to field deployment and continuing after the research year is completed, to ensure the highest quality research publications and scientific meeting presentations, and maximum trainee success in obtaining research and career development grants. Research themes address all topic and geographical areas of interest to trainees and NIH Institutes and Centers, emphasizing both communicable and non-communicable diseases.

Mentors

Haiti
Tanzania
India
Ghana

Current U.S. Fellows

Daniel Oduro, Post-Doctoral Fellow
Assessment of Plasmodium falciparum population structures in Haiti and Ghana in the setting of parasite eradication/decreasing transmission

Olga Tymejczyk, Ph.D. Candidate
Hypertension among adult residents of four slums in Port-au-Prince, Haiti

Past U.S. Fellows

Aynsley Duncan, Medical Student
The effect of 4-drug TB therapy on the number of viable but nonculturable (VBNC) M. tuberculosis in sputum

Justin Kingery, Post-Doctoral Fellow
Incidence of glucose metabolic disorders and hypertension among HIV-infected patients at Weill Bugando in Mwanza, Tanzania

Kathleen Walsh, Post-Doctoral Fellow
A 14 Day Early Bactericidal Activity Study of Nitazoxanide for the Treatment of Tuberculosis in HIV-infected and HIV-uninfected Patients

Contact Information

Infectious Diseases

Roy M. Gulick, M.D., Chief

Center for Global Health

Warren Johnson, M.D., Director
Daniel Fitzgerald, M.D., Co-Director

Lindsey Reif, Program Manager
Tel: (646) 962-8140
lir2020@med.cornell.edu

Division Events

Division News

Clinical Trials